Director Shareholding – 21 April 2010
21 April 2010 – The Board of Craneware plc (AIM: CRW.L), the market leader in automated revenue integrity solutions for the US healthcare market, has been informed that two Directors in the Company have today made the following transactions in ordinary shares of 1p each in the Company (“Ordinary Shares”):
|Name||No. of Ordinary Shares sold||Price||No. of Ordinary Shares post sale||% held post sale|
|Keith Neilson (Chief Executive Officer)||489,756||410p||3,398,044||13.4%|
|Neil Heywood (Non-Executive Director)||7,346||410p||127,926||0.5%|
Keith Neilson remains the largest shareholder in the Company
In addition, Gordon Craig (Chief Technology Officer), who is not a Director of the Company, has today sold 244,878 Ordinary Shares at a price 410p per share. Following this transaction, Mr. Craig has a total holding in the Company of 244,878 Ordinary Shares which represents 12.4% of the total issued share capital.
For further information, please contact:
- +44 (0) 131 550 3100
- Keith Neilson, CEO
- Craig Preston, CFO
- +44 (0) 20 7418 8900
- Oliver Scott
- Nicholas Marren
- +44 (0) 20 7653 9850
- Caroline Evans-Jones
- Fiona Conroy
Founded in 1999, Craneware has headquarters in Edinburgh, Scotland with offices in Atlanta and Arizona, employing over 200 staff. Craneware is the leader in automated revenue integrity solutions that improve financial performance and mitigate risk for healthcare organisations. Craneware’s market-driven, annuity SaaS solutions help hospitals and other healthcare providers more effectively price, charge and code for services and supplies associated with patient care. These optimise reimbursement, increase operational efficiency and minimize compliance risk. By partnering with Craneware, clients achieve the visibility required to identify, address and prevent revenue leakage. To learn more, visit craneware.com.
You might also like...
Sep 10, 2018 | Announcements
10 September 2018 - Craneware (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, announces that Keith Neilson, CEO of the Company, on 7 September purchased a total of 4,848 ordinary shares of 1p each...read more